FDA Inspection
Bristol-Myers Squibb CompanyFDA Inspection 1208871 - Bristol-Myers Squibb Company - June 16, 2023
Discuss this record with AI
Record Details
This FDA Inspection record concerns Bristol-Myers Squibb Company, with an inspection on June 16, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
Open in Dashboard
ID · ad863020-b34a-40d2-91ba-237fdca75cc3
Violation Codes4
21 CFR 211.100(a)21 CFR 211.137(a)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(5)
Full citation text and observation details available on the Dashboard.